Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
- PMID: 10373119
- DOI: 10.1126/science.284.5422.1994
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
Abstract
In contrast with the prevailing view that most tumors and metastases begin as avascular masses, evidence is presented here that a subset of tumors instead initially grows by coopting existing host vessels. This coopted host vasculature does not immediately undergo angiogenesis to support the tumor but instead regresses, leading to a secondarily avascular tumor and massive tumor cell loss. Ultimately, however, the remaining tumor is rescued by robust angiogenesis at the tumor margin. The expression patterns of the angiogenic antagonist angiopoietin-2 and of pro-angiogenic vascular endothelial growth factor (VEGF) suggest that these proteins may be critical regulators of this balance between vascular regression and growth.
Similar articles
-
New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.Oncogene. 1999 Sep 20;18(38):5356-62. doi: 10.1038/sj.onc.1203035. Oncogene. 1999. PMID: 10498889 Review.
-
Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.J Clin Invest. 2002 Mar;109(6):777-85. doi: 10.1172/JCI14105. J Clin Invest. 2002. PMID: 11901186 Free PMC article.
-
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.Cancer Res. 2003 Jun 15;63(12):3403-12. Cancer Res. 2003. PMID: 12810677
-
Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8219-24. doi: 10.1073/pnas.122109599. Epub 2002 Jun 4. Proc Natl Acad Sci U S A. 2002. PMID: 12048246 Free PMC article.
-
Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.Genes Dev. 1999 May 1;13(9):1055-66. doi: 10.1101/gad.13.9.1055. Genes Dev. 1999. PMID: 10323857 Review. No abstract available.
Cited by
-
Preliminary study of CT in combination with MRI perfusion imaging to assess hemodynamic changes during angiogenesis in a rabbit model of lung cancer.Onco Targets Ther. 2013 Jun 17;6:685-92. doi: 10.2147/OTT.S45403. Print 2013. Onco Targets Ther. 2013. PMID: 23836981 Free PMC article.
-
Association between tissue hypoxia, perfusion restrictions, and microvascular architecture alterations with lesion-induced impairment of neurovascular coupling.J Cereb Blood Flow Metab. 2022 Mar;42(3):526-539. doi: 10.1177/0271678X20947546. Epub 2020 Aug 12. J Cereb Blood Flow Metab. 2022. PMID: 32787542 Free PMC article.
-
Osteogenic stimulatory conditions enhance growth and maturation of endothelial cell microvascular networks in culture with mesenchymal stem cells.J Tissue Eng. 2012;3(1):2041731412443236. doi: 10.1177/2041731412443236. Epub 2012 Apr 4. J Tissue Eng. 2012. PMID: 22511994 Free PMC article.
-
Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction.PLoS One. 2012;7(3):e34790. doi: 10.1371/journal.pone.0034790. Epub 2012 Apr 16. PLoS One. 2012. PMID: 22523530 Free PMC article.
-
Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer.EMBO Mol Med. 2021 Jul 7;13(7):e08253. doi: 10.15252/emmm.201708253. Epub 2021 Jun 14. EMBO Mol Med. 2021. PMID: 34125494 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical